Furthermore, the IPRS signature was also found to be an independent prognostic factor for breast cancer after adjustment by clinicopathologic factors (subtype, ER status, HER2 status, PR status, grade, tumor size, and tumor stage). Here, ERBB2 is linked to neoplasm.